Allevi
acquired by 3D Systems3 known investors
Find your way into Allevi
Sign up to see every warm intro you have to Allevi
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allevi team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by 3D Systems May 2021 · terms undisclosed · source ↗
Allevi, part of 3D Systems, makes desktop 3D bioprinters and bioinks used by academic and industry research labs to design and engineer 3D tissues. Its tools support work in regenerative medicine, drug testing, and disease research.
Investors · 3
500 Globallisted by 500 GlobalPalo Alto · $150K
How we know: open dataset · 500 Global portfolio 2026-08 · Not right? Tell us
Frequently asked questions
- What does Allevi do?
- Allevi, part of 3D Systems, makes desktop 3D bioprinters and bioinks used by academic and industry research labs to design and engineer 3D tissues. Its tools support work in regenerative medicine, drug testing, and disease research.
- Who are Allevi's investors?
- Allevi's investors include 500 Global, FundersClub, Space Capital.
- Who acquired Allevi?
- Allevi was acquired by 3D Systems.



